Pembrolizumab, an antibody drug already used to treat other forms of cancer, can be effective in the treatment of the most common form of mesothelioma, according to a new study. The work is the first to show a positive impact from checkpoint inhibitor …
Dr. Pietro Bertino can envision a time when mesothelioma cancer no longer exists. He can see it through the work he does every day. Bertino is an assistant researcher in the Cell and Molecular Biology Department at the John A. Burns School of Medicine at the University of Hawaii. The U.S. Department of Defense awarded…
The post Mesothelioma Vaccine Aims to Stop Cancer Before It Begins appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
Mesothelioma is difficult to treat for a number of reasons. The long latency period before initial diagnosis means that the cancer is typically in advanced stages by the time it is discovered. A built-up resistance to common cancer treatments also makes it difficult for treatment to have a positive effect on cancer victims. This contributes
A recent study shows heating malignant tumors could improve treatments for mesothelioma and other cancers. Researchers in France successfully softened malignant tumors by heating them, a process known as nanohyperthermia, which altered the collagen fibers and reduced the rigidity and volume of the tumors, making them more susceptible to chemotherapy and other therapeutic treatments. Malignant…
The post Heating Tumors May Improve Mesothelioma Treatments appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
A recent study shows heating malignant tumors could improve treatments for mesothelioma and other cancers. Researchers in France successfully softened malignant tumors by heating them, a process known as nanohyperthermia, which altered the collagen fibers and reduced the rigidity and volume of the tumors, making them more susceptible to chemotherapy and other therapeutic treatments. Malignant…
The post Heating Tumors May Improve Mesothelioma Treatments appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
Dr. Ka-Kit Hui is no expert on mesothelioma cancer, but he helps mesothelioma patients live longer and better lives every day. Committed to teaching the benefits of integrative medicine, Hui’s vision blends the best of traditional Chinese and conventional Western medicines, skillfully bridging the gap between the two. He launched the UCLA Center for East-West…
The post Mesothelioma Patients Benefit from Integrative Medicine Expert appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
Italian researchers have discovered that asbestos can travel as far as the gallbladder in patients who have been diagnosed with pleural mesothelioma.
Gavett, S., C. Parkinson, G. Willson, C. Wood, A. Jarabek, K. Roberts, U. Kodavanti, AND D. Dodd. Persistent Effects of Libby Amphibole and Amosite Asbestos Following Subchronic Inhalation in Rats.
Hartford Connecticut Financial Company signed a $1.5 billion reinsurance agreement to cover its asbestos and environmental liability exposures.
Mesothelioma. For most of us, the name of this asbestos-caused lung cancer is synonymous with bad late-night TV commercials imploring those afflicted to sue for contracting the disease.
ALTON Simmons Hanly Conroy , one of the nation’s largest mass torts firms, is pleased to announce that the firm has grown its shareholder ranks with the elevation of 14 attorneys, effective Jan. 1. The firm’s new shareholders are Karoline Carstens , W. Brent Copple , Kenneth P. Danzinger , Suvir Dhar , Ryan Dickherber , Cody Favilla , Crystal Foley , John Foley , Courtney Gregory , Ryan Kiwala , Chris Levy , John Richardson , Andrew S. Williams and Brent Zadorozny . All of the newly named shareholders are based in the firm’s Alton office, except Danzinger, who works from Chicago, and Crystal Foley and Zadorozny, who both are based in the firm’s El Segundo, Calif., office.
Aduro Biotech, Inc. , a biopharmaceutical company with three distinct immunotherapy technologies, announced today a clinical collaboration with Merck . The companies will investigate the combination of CRS-207, Aduro’s LADD based immunotherapy, with Merck’s anti-PD-1 therapy KEYTRUDAA for the treatment of gastric cancer.
An international research team is exploring how variants of an important blood protein could be the key to prevention and early detection of malignant mesothelioma. Dr. Haining Yang at the University of Hawaii Cancer Center is leading the research and recently presented potential strategies at the 6th International Symposium on Malignant Pleural Mesothelioma. Previously, Yang…
The post Early Detection of Mesothelioma Lies in HMGB1 Isoforms appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
David Bennett, 63, was one of thousands of people employed by Smart and Brown, in Spennymoor, during the 1960s and 70s David Bennett, who is now retired and lives in Croxdale, County Durham , was diagnosed with mesothelioma in March 2016 – a cancer of the lung’s linings usually caused by exposure to asbestos. The 63-year-old instructed lawyers at Irwin Mitchell to investigate how and where he was exposed to asbestos dust.
PROTIP: Press ‘i’ to view the image gallery, ‘v’ to view the video gallery, or ‘r’ to view a random entry. Mesothelioma Ad Copypasta refers to a transcript from an personal injury attorney’s advertisement directed toward those suffering from asbestos-related cancer, which is often used as a non-sequitur punchline in various image macros online.